Procurement Summary
Country: Chile
Summary: Medicamentos Bevacizumab Ipililumab Rituximab Hc
Deadline: 30 Sep 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 126078144
Document Ref. No.: 1058012-69-LQ25
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
The purpose of the tender is to have supply contracts for the acquisition of "Bevacizumab, iPililumab, Rituximab HCM 2026-2027", which allow the timely supply of the necessary products in the care of the hospital users for the 2026 - 2027 the circumstances that these products were not provided by the National Central for Supply of Health Services, nor are they available in electronic catalogs of the Framework Agreement, in coordinated purchases and/or joint purchases of the Ministry of Health, or its acquisition be disadvantageous with respect to the result of this tender, nor exist on the ownership of other state agency or shared services that allow satisfying the requirement, whose most advantageous conditions will be informed at the time corresponding to the purchasing address, in in accordance with the provisions of the D.S. Treasury.
Products or services: pharmacies, Rituximab
Documents
Tender Notice